SCHEMBL1184785

SCHEMBL1184785

COc1ccc2c(c1)C(=O)C(C(=O)O)CC(=O)N2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.55
PDE3A Q14432 1/20 0.55
ALDH1A1 P00352 5/20 0.48
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
ACHE P22303 1/20 0.43
LRRK2 Q5S007 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
GSK3B P49841 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
HIF1A Q16665 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1185886 0.80 ALDH1A1 (0.49) ALDH1A1ACHELRRK2TP53KMT2A
SCHEMBL6881129 0.79 ACHE (0.63) ALDH1A1ACHEGAAKDM4EHPGD
SCHEMBL11775988 0.76 ALDH1A1 (0.67) ALDH1A1MAOAMAOBSMN1; SMN2GAA
SCHEMBL1184763 0.74 ALDH1A1 (0.49) ALDH1A1ACHESMN1; SMN2TP53KDM4E
SCHEMBL7826091 0.73 PDE3B (0.50) PDE3BPDE3AALDH1A1MAOAMAOB
SCHEMBL4622406 0.72 SMN1; SMN2 (0.44) PDE3BPDE3AALDH1A1MAOAMAOB
SCHEMBL2258919 0.71 ALDH1A1 (0.49) ALDH1A1CCNB2CDK1CCNB1GSK3B
SCHEMBL7979383 0.71 CYP19A1 (0.55) ALDH1A1MAOBACHESMN1; SMN2KDM4E
SCHEMBL14395399 0.71 ATM (0.47) ALDH1A1MAOBACHEGAAKDM4E
SCHEMBL4622631 0.70 SRC (0.44) PDE3BPDE3AALDH1A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799684-B1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS MILLENNIUM PHARM INC (US) 2014-12-03 EP disclosed
US-20120178739-A1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 US disclosed
US-7935694-B2 Lactam compounds useful as protein kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-05-03 US disclosed
US-20110039820-A1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-02-17 US disclosed
US-20090105213-A1 Lactam compounds useful as protein kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2009-04-23 US disclosed
US-7459448-B2 Lactam compounds useful as protein kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2008-12-02 US disclosed
US-20060100194-A1 Lactam compounds useful as protein kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100194-A1 Lactam compounds useful as protein kinase inhibitors PRKCI, PIK3CA, AKT1 PDE3B 698/4885PDE3A 866/4885ALDH1A1 4635/4885
US-20120178739-A1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS PRKCI, PIK3CA, AKT1 PDE3B 698/4885PDE3A 866/4885ALDH1A1 4635/4885
US-20090105213-A1 Lactam compounds useful as protein kinase inhibitors PRKCI, PIK3CA, AKT1 PDE3B 698/4885PDE3A 866/4885ALDH1A1 4635/4885
US-20110039820-A1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS PRKCI, PIK3CA, AKT1 PDE3B 698/4885PDE3A 866/4885ALDH1A1 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.